Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “De Novo Kidney Transplant Recipients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT00769613
What this trial is testing

Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections

Who this might be right for
Cancer
Milton S. Hershey Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT00239798
What this trial is testing

Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 255
Post-approval studies (Phase 4)Study completedNCT00261820
What this trial is testing

Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients

Who this might be right for
Graft RejectionKidney FailureKidney Transplantation
Wyeth is now a wholly owned subsidiary of Pfizer 160
Post-approval studies (Phase 4)Study completedNCT00154245
What this trial is testing

A One-year, Open Label Study to Investigate the Safety and the Effect of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion in de Novo Kidney Transplant Recipients.

Who this might be right for
Kidney Transplantation
Novartis 20
Large-scale testing (Phase 3)Study completedNCT00378014
What this trial is testing

Preservation of Renal Function in Liver Transplant Recipients With Certican Therapy

Who this might be right for
Liver Transplantation
Novartis Pharmaceuticals 276
Large-scale testing (Phase 3)Study completedNCT01625377
What this trial is testing

A National Multi-center Randomized, Open Label Study to Evaluate Efficacy and Safety of Everolimus With EC-MPS Compared to Standard Treatment Combination Tacrolimus and EC-MPS in de Novo Liver Transplant Recipients

Who this might be right for
Liver Transplantation
Novartis Pharmaceuticals 188
Post-approval studies (Phase 4)Study completedNCT00275522
What this trial is testing

The Comparison of Three Different Immunosuppressant Regimens in Kidney Transplant Recipients.

Who this might be right for
Kidney Transplant
Mayo Clinic 16
Early research (Phase 1)Active Not RecruitingNCT03726307
What this trial is testing

Allogeneic Regulatory Dendritic Cell (DCreg) Renal Study

Who this might be right for
Kidney TransplantRenal Transplant Recipients
Angus W. Thomson PhD DSc 28
Testing effectiveness (Phase 2)Ended earlyNCT00282230
What this trial is testing

Evaluate the Safety and Efficacy of Prograf/FK778 and Prograf/MMF in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Astellas Pharma Inc 150
Post-approval studies (Phase 4)Study completedNCT01183247
What this trial is testing

An Open, Single Centre, Randomised, Parallel Group Study to Investigate Three Different Immunosuppressive Regimens

Who this might be right for
Comparative StudyImmunosuppressive Agents
University Hospital, Basel, Switzerland 63
Large-scale testing (Phase 3)Study completedNCT02040584
What this trial is testing

A Multicentre, Randomised, Open-label, Controlled, 12-month Follow-up Study to Assess Impact on Renal Function of an Immunosuppression Regimen Based on Tacrolimus Minimisation in Association With Everolimus in de Novo Liver Transplant Recipients.

Who this might be right for
Liver Transplant
Novartis Pharmaceuticals 217
Post-approval studies (Phase 4)Study completedNCT00634920
What this trial is testing

Evaluation of Early Conversion to Everolimus From Cyclosporine in de Novo Renal Transplant Recipients

Who this might be right for
Renal Function
Novartis Pharmaceuticals 204
Large-scale testing (Phase 3)Ended earlyNCT00137345
What this trial is testing

Study Comparing Sirolimus With Cyclosporine in a Calcineurin Inhibitor (CNI)-Free Regimen in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Wyeth is now a wholly owned subsidiary of Pfizer 500
Testing effectiveness (Phase 2)Study completedNCT00307125
What this trial is testing

Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies

Who this might be right for
Kidney TransplantKidney Transplant RecipientGraft Function/Survival+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 757
Post-approval studies (Phase 4)Study completedNCT00238953
What this trial is testing

Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis 30
Post-approval studies (Phase 4)Study completedNCT00306397
What this trial is testing

Pilot Study to Investigate a Steroid Free Immunosuppressive Regimen for Renal Transplant Recipients

Who this might be right for
Kidney Transplantation
University Hospital, Basel, Switzerland 100
Large-scale testing (Phase 3)Study completedNCT00154284
What this trial is testing

Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant Patients

Who this might be right for
Organ Transplantation, Renal Transplantation
Novartis 114
Post-approval studies (Phase 4)Study completedNCT02723591
What this trial is testing

To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Formation and the Development of Immune Activation (IA) in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Astellas Pharma Global Development, Inc. 599
Large-scale testing (Phase 3)Study completedNCT06001320
What this trial is testing

De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Transplant Recipients

Who this might be right for
Kidney Transplant; ComplicationsCMV
Virginia Commonwealth University 30
Post-approval studies (Phase 4)Ended earlyNCT01371344
What this trial is testing

A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft Recipients

Who this might be right for
Heart TransplantationKidney TransplantationLiver Transplantation
Astellas Pharma Europe Ltd. 47
Next Page